Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 23:7:221.
doi: 10.1186/1752-1947-7-221.

Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report

Affiliations

Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report

Malgorzata Biernacka-Zielinska et al. J Med Case Rep. .

Abstract

Introduction: Antiphospholipid syndrome is a multisystem autoimmune disease characterized by arterial and/or venous thrombosis and persistent presence of antiphospholipid antibodies. It can be a primary disease or secondary when associated with other autoimmune diseases.

Case presentation: We present a case of a 16-year-old Caucasian boy with a massive arterial and venous thrombosis in his lower limbs as well as in his central nervous system with clinical symptoms such as headaches and chorea. He did not present any clinical or laboratory signs of a systemic inflammatory connective tissue disease, including systemic lupus erythematosus. Based on the clinical picture and results of the diagnostic tests (positive antibodies against β2-glycoprotein and a high titre of anticardiolipin antibodies) we finally diagnosed primary antiphospholipid syndrome. During a 9-month follow up after the acute phase of the disease, he was treated with low-molecular-weight heparin. Neurological symptoms were relieved. Features of recanalization in the vessels of his lower limbs were observed. After a subsequent 6 months, because of the failure of preventive treatment - an incident of thrombosis of the vessels of his testis - treatment was modified and heparin was replaced with warfarin.

Conclusion: Although the preventive treatment with warfarin in our patient has continued for 1 year of follow up without new symptoms, further observation is needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Thrombosis of the left femoral vein.
Figure 2
Figure 2
Thrombi in the lumen of the left femoral vein.

References

    1. Myones BL. Update on antiphospholipid syndrome in children. Curr Rheumatol Rep. 2011;13:86–89. doi: 10.1007/s11926-010-0148-4. - DOI - PubMed
    1. Hunt BJ. Pediatric antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost. 2008;34:274–281. doi: 10.1055/s-0028-1082271. - DOI - PubMed
    1. Avcin T. Antiphospholipid syndrome in children. Curr Opin Rheumatol. 2008;20:595–600. doi: 10.1097/BOR.0b013e3283060a8c. - DOI - PubMed
    1. Rigante D, Gaspari S, Bersani G, Stabile A. Antiphospholipid syndrome: clinical spectrum and therapeutical/prophylactic strategies in the pediatric population. Eur Rev Med Pharmacol Sci. 2008;12:47–53. - PubMed
    1. Cimaz R, Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin North Am. 2006;32:553–573. doi: 10.1016/j.rdc.2006.05.005. - DOI - PubMed

LinkOut - more resources